Skip to the reporting
My account Sign in Subscribe
3 of 3 free articles left this month Subscribe now
Biotech

Neobe raises $6.8m to engineer bacteria that dissolve the walls around solid tumours

The Stevenage-based company says the funding will carry its lead programme, NEO22, through preclinical work to a regulatory filing in 2028, with a first-in-human trial to be financed…

By Zack Hill

Most read

Trending
Business
Innovation

Our columnists

All columnists

The editors’ selection

The Circuit

One email, 7am, the six things that moved

Written by the desk that reported it, not a summariser. Free, and you can leave whenever.

One email a day. Unsubscribe in one click. We never pass your address on.

See all six briefings →